跳至主要内容
临床试验/NCT00408161
NCT00408161已完成不适用

Contingency Management for Chronic Recidivist Alcohol-Dependent Patients

UConn Health2 个研究点 分布在 1 个国家目标入组 104 人开始时间: 2003年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
104
试验地点
2
主要终点
number of detoxifications

研究概览

简要总结

The purpose of this study is to evaluate the efficacy of prize contingency management (CM) in reducing in-patient detoxification services for chronic recidivist alcohol-dependent patients.

详细描述

This study evaluates the efficacy of prize contingency management (CM) in reducing in-patient detoxification services for chronic recidivist alcohol-dependent patients. 116 alcohol-dependent patients who have received 4 or more alcohol detoxifications in a calendar year will be randomly assigned to one of two 6-month treatment conditions: standard case management treatment, or standard case management treatment plus CM. In the CM condition, patients earn the chance to win prizes by submitting negative breath samples and by complying with steps toward treatment goals, such as attending outpatient substance abuse treatment services, attending appointments with low income housing programs, or complying with outpatient psychiatric treatment. Treatment services received, alcohol and drug use, psychosocial functioning, and HIV risk behaviors will be measured pre-treatment and at months 1, 3, and 6 (post-treatment), and at follow-ups scheduled for 9, 12, and 18 months after intake.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age 18 years or older
  • Four or more inpatient alcohol detoxifications in the previous 12 months
  • current diagnosis of DSM-IV alcohol dependence

排除标准

  • 未提供

结局指标

主要结局

number of detoxifications

时间窗: 9, 12, and 18 months after intake

self-reported alcohol use

时间窗: 9, 12, and 18 months after intake

objective alcohol use

时间窗: 9, 12, and 18 months after intake

次要结局

  • ASI composite scores(9, 12, and 18 months after intake)
  • BSI scores(9, 12, and 18 months after intake)
  • objective drug use(9, 12, and 18 months after intake)
  • HRBS scores(9, 12, and 18 months after intake)

研究者

发起方
UConn Health
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验